Rowinsky Eric K — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Rowinsky Eric K has filed 2 SEC Form 4 filings across 2 companies in the last 90 days.

Profile

Eric K. Rowinsky is identified in SEC filings as a director of Verastem, Inc., a publicly traded oncology-focused company. The filing context indicates he holds a board/director role at Verastem as of the latest filing date (2026-05-26). Beyond this SEC context, no additional biographical details are provided in the filing snippet. Therefore, the publicly verifiable biographical content here is limited to his director role with Verastem.

Board memberships

• Verastem, Inc.

Awards & honors

• Listed as a director of Verastem, Inc. in SEC filings as of 2026-05-26.

Recent Transactions

Companies — Last 90 Days

• BIOGEN INC. (BIIB) — 1 filings, last 2026-06-11
• Verastem, Inc. (VSTM) — 1 filings, last 2026-05-26

Frequently Asked Questions

Who is Rowinsky Eric K?

Eric K. Rowinsky is identified in SEC filings as a director of Verastem, Inc., a publicly traded oncology-focused company. The filing context indicates he holds a board/director role at Verastem as of the latest filing date (2026-05-26). Beyond this SEC context, no additional biographical details are provided in the filing snippet. Therefore, the publicly verifiable biographica…

How many SEC Form 4 filings has Rowinsky Eric K submitted recently?

2 primary Form 4 filings in the last 90 days, covering 2 companies.

Where can I see all of Rowinsky Eric K's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week